The National Agency for Food and Drug Administration and Control has announced the pre-qualification approval for its Yaba Lagos laboratory as a Central Drug Control Laboratory.
The Director-General of NAFDAC, Professor Mojisola Adeyeye, during a news conference held in Abuja on Thursday, revealed that the World Health Organisation recently granted the approval of the CDCL.
According to her, the approval of the laboratory for the agency was a significant milestone in its dedication to ensuring the safety and quality of pharmaceutical products.
According to her, the pre-qualification approval was communicated to the agency via mail received from the WHO pre-qualification inspection team on September 15.
She further explained that the success was finally published on the WHO website, adding that the website address through which the public could cite and reference was equally shared with the agency for dissemination.
Adeyeye said, “You can access the information on the pre-qualification procedure, as well as the list of pre-qualified quality control laboratories, on the pre-qualification unit medicine website: https://extranet.who.int/pqweb/medicines.
” NAFDAC is Nigeria’s regulatory body responsible for ensuring the safety and quality of food, drugs, cosmetics, medical devices and other related products.
“NAFDAC’s mission is to safeguard public health by ensuring that only safe and wholesome products are made available to the Nigerian public.
“This is a huge landmark achievement for the agency and Nigeria. Very few laboratories in the world have the apex status of WHO pre-qualification.
” Our journey towards this milestone started in 2010, but with renewed efforts and more commitment to attempts by our management and Federal Government in the last four years, we have finally achieved this goal.
“The WHO pre-qualification of the CDCL is a testament to the unwavering commitment of NAFDAC to meeting international standards of excellence in drug quality control and regulation.”
She noted that the recognition brought numerous benefits to CDCL, NAFDAC, and most importantly Nigerians.
The NAFDAC DG described the WHO pre-qualification to Nigeria as global recognition that will enhance pharmaceutical quality, international collaboration, advance public health, streaming regulatory process, enhancement of credibility and advancement of Nigeria’s healthcare system.
She said the achievement would not have been possible without the hard work, dedication and unwavering commitment of the Minister of Health, NAFDAC management, CDCL staff and other partners that include WHO Nigeria country office, USP PQM + Nigeria country office and Global Fund.
According to Adeyeye, the status underscored the agency’s commitment to safeguarding public health and improving healthcare access for all Nigerians.
She, however, said that the agency would continue to work to uphold the highest standards of pharmaceutical quality control and regulation.
The NAFDAC DG said the agency remains committed to its mission of safeguarding public health by ensuring safe, effective and quality medicines and healthcare products available to Nigerians.
“We will leverage on the achievements to strengthen the partnership and enhance healthcare access, as well as contribute to the overall improvement of public health in Nigeria and the West African region,” she added.
(NAN)
